Vio3/Apc3
Payments companies reported to CMS as associated with Vio3/Apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3/Apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3/Apc3
These are the largest totals companies reported as associated with Vio3/Apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Yasser Etman | Dallas, TX | Pulmonary Disease | $147.83 |
| Shreyash Pradhan | Denver, CO | Surgery | $115.35 |
| Elaheh Harrington | East Syracuse, NY | Gastroenterology (Internal Medicine) | $100.00 |
| Abid Javed | Miami, FL | Gastroenterology (Internal Medicine) | $100.00 |
| Sunny Sandhu | Stanford, CA | Gastroenterology (Internal Medicine) | $100.00 |
| Nisa Desai | Boston, MA | Internal Medicine | $100.00 |
| Bishr Swar | Oklahoma City, OK | Gastroenterology (Internal Medicine) | $75.98 |
| Katherine Janike | Chicago, IL | Gastroenterology (Internal Medicine) | $75.98 |
| Katy Jackson | Oklahoma City, OK | Gastroenterology (Internal Medicine) | $75.98 |
| Amir Rumman | Charlottesville, VA | Gastroenterology (Internal Medicine) | $75.98 |
Prescribed Vio3/Apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.